38E-21892-93698
4 vaccinations
8 coded responses
53 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Registered in v-safe
-
2021-02-19
Dose 1 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
-
2021-03-12
Dose 2 — Pfizer-BioNTech
- 2021-03-12
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Painful, swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Ssollen lymph node left armpit (same side as shot)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-06-11
- 2021-09-10
-
2021-11-22
Dose 3 — Pfizer-BioNTech
- 2021-11-22
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Itching · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · HeadacheAdult check-in
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — day 35, dose 3MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach flu (caught from daughter who tested negative for covid and the flu).MedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
- 2022-02-21
- 2022-05-23
-
2022-10-21
Dose 4 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
-
2022-11-14
Survey response — day 21, dose 4MedDRA: Nasopharyngitis, Rhinorrhoea, Sinus pain — Feeling: FairFree text: Had sinus pain and a runny nose over the weekend. Suspect a mild cold.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-18
- 2022-11-25
-
2022-12-03
Survey response — day 42, dose 4MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had stomach flu a few days ago.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-20
Survey response — 3 months, dose 4MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-01-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2023-01-23
Call successfulParticipant prefers to complete VAERS report online
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
| 4 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-20 | Successful 2023-01-23 |
Participant prefers to complete VAERS report online |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Painful, swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Ssollen lymph node left armpit (same side as shot)
Release 10 — day 35, dose 3
Symptoms: Stomach flu (caught from daughter who tested negative for covid and the flu).
Release 12 — day 21, dose 4
Symptoms: Had sinus pain and a runny nose over the weekend. Suspect a mild cold.
Release 12 — day 42, dose 4
Symptoms: Had stomach flu a few days ago.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release